A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
Clinical trial NCT05275400 · COMPLETED
Trial details
- NCT number
- NCT05275400
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2024-05-15
- Enrollment
- 986
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.